Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population

Journal of Endocrinological Investigation

Volumn 32, Issue 3, 2009, Pages 258-262

  Zhang, H M ^a,b   Chen, L L ^a   Wang, L ^c   Liao, Y F ^a   Wu, Z H ^b   Ye, F ^b   Xu, S ^c   Yi, L L ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Endocrinology ^*  (China)

^c Xin Hua Hospital   (China)

Author keywords

Diabetic retinopathy; Haplotype; Receptor for advanced glycation end products; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; GLUCOSE TOLERANCE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; RAGE GENE; RISK FACTOR;

EID: 67651244307     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346463     Document Type: Article

References (19)

1. Klein R, Klein BE, Moss SE, Wong TY. Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2007, 114: 1884-1892 (Pubitemid 47483910)
2. Yeh CH, Sturgis L, Haidacher J, et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes 2001, 50: 1495-1504 (Pubitemid 32500185)
3. Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V. Novel Advanced Glycation Index and its association with diabetes and Microangiopathy. Metabolism 2005, 54: 1002-1007
4. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993, 143: 1699-1712 (Pubitemid 24058273)
5. Kanková K, Záhejský J, Márová I, et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Complications 2001, 15: 185-192 (Pubitemid 33714178)
6. Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T. Association of G82S polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002, 16: 391-394 (Pubitemid 35449084)
7. Kanková K, Beránek M, Hájek D, Vlková E. Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study. Retina 2002, 22: 119-121 (Pubitemid 41070767)
8. Yoshioka K, Yoshida T, Takakura Y, et al. Relation between polymorphisms 1704G/T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern Med 2005, 44: 417-421 (Pubitemid 40895094)
9. Kanková K, Stejskalová A, Hertlová M, Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transpl 2005, 20: 1093-1102 (Pubitemid 40862097)
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28: S37-42.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-419 (Pubitemid 15018832)
12. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15: 97-98 (Pubitemid 41653949)
13. Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the recptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998, 47: 1155-1157 (Pubitemid 28294561)
14. Naka CL, Picheth G, Alcântera VM, et al. The Gly82Ser polymorphism of the receptor of advanced glycation end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population. Diabetes Care 2006, 29: 712-713 (Pubitemid 44115382)
15. Liu L, Xiang K. RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care 1999, 22: 646. (Pubitemid 29153056)
16. Kanková K, Vasků A, Hajek D, Záhejský J, Vasků V. Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care 1999, 22: 1745. (Pubitemid 29458404)
17. Hofmann MA, Drury S, Hudson BI, et al. RAGE and arthritis: the G82S polymorphisms amplifies the inflammatory response. Genes Immun 2002, 3: 123-135 (Pubitemid 38961122)
18. Kanková K, Márová I, Záhejský J, et al. Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Metabolism 2001, 50: 1152-1160 (Pubitemid 33034698)
19. Matsunaga-Irie S, Maruyama T, Yamamoto T, et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product 1704G/T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004, 27: 303-307 (Pubitemid 38174048)